SD HEALTHCARERecent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...
BIOTECH: Goal Is Is to Be Operational By the End of 2016
NuVasive Inc., a leading medical device company in San Diego, announced that it will expand its manufacturing operations with the intent to hire hundreds of new employees.
Sequenom Inc., a life sciences company in San Diego, announced that it has entered into a clinical research collaboration with the University of California, San Diego Moores Cancer Center.
Epic Sciences Inc., announced the appointment of Dave Henderson as Epic's chief information officer.
NuVasive Inc., a medical device company in San Diego, announced that it will be expanding its manufacturing operations and hiring hundreds of new employees.
Human Longevity Inc. (HLI), a genomics-based tech company in San Diego, announced Tuesday that Mark A. Winham has joined the company as chief operating officer.
Halozyme Therapeutics Inc., a biotech developing novel oncology and drug-delivery therapies, named Michael J. LaBarre as chief scientific officer.
San Diego-based Beloteca Inc., a pharma company developing generics and reformulations, announced the appointment of Dorla Mirejovsky as chief scientific officer.
Biocept Inc., a molecular diagnostics company, announced the resignation and replacement of its chief financial officer Bill Kachioff.
San Diego’s favorite organic juice company is partnering with an unexpected beverage giant — Coca-Cola.
MEDICAL: Vetting Of Services Provides Key Information, Safety
South Doctors Inc, a downtown startup focused on medical tourism, is vetting the legitimacy of health care treatments sought across the border.
Biotech: Stem Cell Therapy Would Repair Damaged Brain Tissue
International Stem Cell Corp. is entering a human clinical trial to test if the company’s patented stem cell line will repair the brains of Parkinson’s patients.
San Diego's Vical Inc. has won a "qualified infectious disease product" designation from the U.S. Food and Drug Administration for a proposed treatment of invasive aspergillosis, a potentially deadly fungal disease.
Quidel Corp., a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced that Mark A. Pulido has resigned as chairman of the company's Board of Directors, a position he had held for 11 years.
La Jolla Pharmaceutical Co. has signed an exclusive worldwide research and license agreement with Nashville’s Vanderbilt University relating to the university’s research on bone formation.
Medical device maker NuVasive Inc. announced that Johnson Lai has been appointed chief information officer. Lai will be responsible for advancing the company’s information technology systems, process and procedures, according to a recent news release.